Although cardiovascular mortality was lower in the SGLT2i group, the difference did not reach statistical significance.
← all excerpts
Effectiveness and safety of SGLT2 inhibitors in aged patients (≥ 75 Years) with diabetes: a multi-center retrospective cohort study.
1
—
—